Cavadex

Cavadex® | Innovating Heart Health At Cavadex®, we are dedicated to transforming cardiovascular care with cutting-edge science. Our proprietary compound, 2-hydroxypropyl-β-cyclodextrin, is the only cyclodextrin proven to safely reduce arterial plaque and improve heart health. Backed by over 30 years of FDA approved cyclodextrin research, Cavadex® offers a groundbreaking solution for managing atherosclerosis and supporting overall cardiovascular wellness. We work closely with leading cardiologists, researchers, and healthcare professionals to deliver a product that redefines how cardiovascular disease is treated. Our commitment to innovation, safety, and patient outcomes drives us to make this life-changing therapy accessible to individuals globally. What We Offer: • Scientifically proven treatment for reducing arterial plaque • Support for cholesterol management and cardiovascular health • Global distribution and customer support Join us in our mission to make heart health more achievable, one patient at a time. Learn more at: www.cavadex.com Follow us for updates on cardiovascular innovation and patient success stories.